Guardant Health (STU:5GH) Construction In Progress : €26.9 Mil (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Guardant Health Construction In Progress?

Guardant Health's quarterly construction in progress declined from Jun. 2024 (€6.9 Mil) to Sep. 2024 (€6.5 Mil) but then increased from Sep. 2024 (€6.5 Mil) to Dec. 2024 (€26.9 Mil).

Guardant Health's annual construction in progress declined from Dec. 2022 (€19.4 Mil) to Dec. 2023 (€6.9 Mil) but then increased from Dec. 2023 (€6.9 Mil) to Dec. 2024 (€26.9 Mil).

Guardant Health Construction In Progress Historical Data

The historical data trend for Guardant Health's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guardant Health Construction In Progress Chart

Guardant Health Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Construction In Progress

Get a 7-Day Free Trial

6.44

49.45

19.45

6.89

26.87

Guardant Health Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Construction In Progress	Get a 7-Day Free Trial															6.89	7.76	6.85	6.53	26.87

Guardant Health Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Guardant Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Guardant Health Inc (STU:5GH) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

GH:USA GH:Mexico

Address

3100 Hanover Street, Palo Alto, CA, USA, 94304

Website

https://www.guardanthealth.com

Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Guardant Health Headlines

No Headlines